This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
Settings
This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
This cookie is used for system purposes only and does not track user actions. It is required for normal functioning of this web site.
This is a web analytics service.
Processing company
  • Google Ireland Limited
  • Google Building Gordon House, 4 Barrow St, Dublin, D04 E5W5, Ireland
Data Purposes
  • Marketing
  • Advertisement
  • Web Analytics
Technologies Used
  • Cookies
  • Pixel Tags
Data Attributes
  • IP address (anonymised)
  • Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
  • Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • IP address
  • Date and time of visit
  • Usage data
  • Click path
  • App updates
  • Browser information
  • Device information
  • JavaScript support
  • Pages visited
  • Referrer URL
  • Downloads
  • Flash version
  • Location information
  • Purchase activity
  • Widget interactions
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 (1) (a) GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Alphabet Inc.
This is a Tracking technology offered by Facebook and used by other Facebook services such as Facebook Custom Audiences.
Processing company
  • Facebook Ireland Limited
  • 4 Grand Canal Square, Grand Canal Harbour, Dublin, D02, Ireland
Data Purposes
  • advertising
  • Marketing
  • Retargeting
  • Analyse
  • Tracking
Technologies Used
  • Cookies
Data Attributes
  • Pixel specific data
  • Http-Header
  • Optional Parameters
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • Facebook user ID
  • Browser information
  • Usage data
  • Geräteinformationen
  • Non-sensitive custom data
  • Referrer URL
  • Pixel ID
  • Location information
  • Pixel specific data
  • User behaviour
  • Ads viewed
  • Interactions with advertisement, services, and products
  • Marketing information
  • Content viewed
  • IP address
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 para. 1 s. 1 lit. a GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Facebook Inc.
This is a web analytics service.
Processing company
  • Zoom Analytics Ltd.
  • Petah Tikva, Israel
Data Purposes
  • Marketing
  • Advertisement
  • Web Analytics
Technologies Used
  • Cookies
  • Pixel Tags
Data Attributes
  • IP address (anonymised)
  • Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
  • Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • IP address
  • Date and time of visit
  • Usage data
  • Click path
  • App updates
  • Browser information
  • Device information
  • JavaScript support
  • Pages visited
  • Referrer URL
  • Downloads
  • Flash version
  • Location information
  • Purchase activity
  • Widget interactions
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 (1) (a) GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Alphabet Inc.
Hemofarm Presented the Sustainability Report for 2020
29. September 2021.

BUSINESS RESPONSIBILITY, SAFEGUARDS HEALTH IN PRACTICE


Belgrade, September 29, 2021 – In the year when the survival of humankind was put to the test, Hemofarm persisted in its sustainable development efforts – it preserved the health and defended trust by practicing responsible attitude towards resources and environment. During the pandemic year 2020 and with the utmost commitment of 3,800 employees and four-shift operation, the company managed to achieve the record-breaking output and provide for the safe supply of all markets where Stada operates with the high-quality medicinal products, this is the summary of the just published Hemofarm’s Sustainability Report for 2020.

The latest report titled ’Life Wins with Us’ has been designed as a part of the triptych 2019-2021 with the aim to illustrate the trend of all parameters of business operations and sustainability of the company amidst, during and after the pandemic. This time processed cotton paper was used by Hemofarm for printing its new report, emphasizing thus the significance of recycling, reuse of raw materials and circular economy.

’Apart from the fight for people’s health, the Covid-19 pandemic showed that caring about how much of an impact you leave on society and the environment in which you live is one of the most important contributions to public health. When it comes to Hemofarm's business in the peak pandemic year, we have continued to move up the path of sustainability. Out of the 6.5 billion tablets and other forms we have produced, as many as 83 percent have been packed in recycled cardboard packaging material. We launched 17 new brands, and the successful acquisitions carried out by Stada meant the integration of new products and portfolio expansion for us. Most importantly, Hemofarm has successfully defended the health of society. We have shown by personal example what responsible business means in times of crisis, and sustainable development is important because it, above all, means responsibility towards employees, society and the community’, said dr Ronald Seeliger, CEO of Hemofarm.

According to the Resident Coordinator of UN in Serbia, her Excellency Francoise Jacob, sustainable development, fighting climate change and inequalities for a better life for all, is a shared responsibility between the state, the citizens, the private sector, the municipalities. ’This report is a call to action for the entire private sector to adopt universal principles and standards of sustainable development, on human rights, labour rights, environmental rights, and anticorruption. The transformation of our economic model towards sustainability cannot happen without the full contribution of the private sector, including banking, insurance, construction sectors. The UN is committed to support Serbia in this pathway to a prosperous future – fostering innovation and sharing best practices, unlocking business value and new opportunities, building business resilience, and enabling long-term sustainable growth and well-being. I hope large and small companies will take more ambitious and comprehensive action across their operations and value chains, while building new missions for their teams and employees, and setting goals in line with international standards and national ambitions’, said H.E. Jacob at the presentation of Hemofarm’s new Sustainability Report.

Hemofarm celebrated its 60th jubilee anniversary with the slogan ’Life Wins with Us’ and special thanks was extended on that occasion to colleagues from production who represent ’silent heroes’ of the pandemic. Together with health professionals and pharmacists, they were the first line of defence from the pandemic and Hemofarm supported their responsible mission also through donation of medical equipment to healthcare institutions in regions it operates in (Serbia, B&H and Montenegro).

Additional indicators of Hemofarm’s operations in 2020:

• Out of 3,800 employees, the majority are women – as many as 54 percent, and the majority of them are also represented in the company’s management. Of course, women and men in Hemofarm are equally paid for the same jobs they perform.
• During the peak of the pandemic, special incentives were provided for employees working in high-risk areas.
• Our portfolio was additionally expanded (410 products) and it covers as many as 13 out of 14 pharmacotherapeutic groups.
• About 83 percent of our products is packed in packaging material made of recycled cardboard.
• The use of recycled cardboard saved 34 days of electricity and water usage for 28 days, and additional 13,433 trees were saved.
• Donation of 110 monitors for monitoring of patients’ condition, worth almost 400 thousand euros, for strengthening of public health institutions in Serbia and work of doctors, medical staff and pharmacists.
• Employees underwent 7.555 internal and external trainings and accomplished 15.110 hours of education.
• Mentors from Hemofarm invested totally 714 working hours of volunteer work in the development of future professionals, which is about 18 working weeks or 90 working days.
• Hemofarm Foundation implemented almost 80 activities from the field of health, education and culture, through 137 partnerships with institutions and organizations.
• The project ’Together We Can Do All’ offered Hemofarm’s employees support in preservation of mental health in challenging times.

New Hemofarm’s Sustainability Report is available at SUSTAINABLE DEVELOPMENT.

Hemofarm odrzivi razvoj

Hemofarm odrzivi razvoj

Hemofarm odrzivi razvoj

Hemofarm odrzivi razvoj

Hemofarm odrzivi razvoj

Hemofarm odrzivi razvoj

Hemofarm odrzivi razvoj